Cargando…

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years

CONTEXT: Erythrocytosis is a known side effect of testosterone therapy that can increase the risk of thromboembolic events. OBJECTIVES: To study the prevalence and determinants in the development of erythrocytosis in trans men using testosterone. METHODS: A 20-year follow-up study in adult trans men...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madsen, Milou Cecilia, van Dijk, Dennis, Wiepjes, Chantal Maria, Conemans, Elfi Barbara, Thijs, Abel, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118580/ https://www.ncbi.nlm.nih.gov/pubmed/33599731 http://dx.doi.org/10.1210/clinem/dgab089

Ejemplares similares

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long Term Follow up Study on Prevalence, Determinants, and the Effect of Years of Exposure
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022)

Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations
por: Madsen, Milou Cecilia, et al.
Publicado: (2022)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

FRI431 Erythrocytosis Associated With Oral Testosterone Replacement
por: Engel, Ashley A, et al.
Publicado: (2023)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Change in grip strength in trans people and its association with lean body mass and bone density
por: Scharff, Miranda, et al.
Publicado: (2019)

Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy
por: Collet, Sarah, et al.
Publicado: (2022)

Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis
por: Cangiano, B, et al.
Publicado: (2017)

Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
por: de Blok, Christel JM., et al.
Publicado: (2021)

OR31-01 The Dose-dependent Effect Of Estrogen On Bone Mineral Density In Trans Girls
por: Boogers, Lidewij S, et al.
Publicado: (2023)

Testosterone-Secreting Ovarian Tumor: A Rare Cause of Erythrocytosis and Pulmonary Embolus
por: Friedman, Naomi, et al.
Publicado: (2020)

The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open-label, randomised controlled trial
por: van Zijverden, Lieve Mees, et al.
Publicado: (2023)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Defreyne, Justine, et al.
Publicado: (2020)

MON-913 Testosterone Secreting Ovarian Tumor: A Rare Cause of Erythrocytosis and Pulmonary Embolus
por: Friedman, Naomi, et al.
Publicado: (2020)

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy
por: Schumacher, Kamilya A., et al.
Publicado: (2022)

SURPRISING ERYTHROCYTOSIS RESOLUTION AFTER MYOMECTOMY: MYOMATOUS ERYTHROCYTOSIS SYNDROME
por: Couillandre, Pauline, et al.
Publicado: (2023)

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
por: Pastuszak, Alexander W, et al.
Publicado: (2015)

Genetic Background of Congenital Erythrocytosis
por: McMullin, Mary Frances
Publicado: (2021)

Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis‐associated genes in the Slovenian family with idiopathic erythrocytosis
por: Kristan, Aleša, et al.
Publicado: (2021)

Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders
por: Corante, Noemí, et al.
Publicado: (2018)

Excessive Erythrocytosis Is Not Associated With Altered Iron Homeostasis in Men From the World’s Highest City
por: Cairo, Gaetano, et al.
Publicado: (2023)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Erythrocytosis associated with IgA nephropathy
por: Cohen, Camille, et al.
Publicado: (2021)

Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non‐neoplastic erythrocytosis patients
por: Mori, Yosuke, et al.
Publicado: (2022)

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019)

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study
por: de Nie, Iris, et al.
Publicado: (2021)

Idiopathic erythrocytosis in a patient on chronic hemodialysis
por: Lee, Dong Hyun, et al.
Publicado: (2015)

The role of PHD2 mutations in the pathogenesis of erythrocytosis
por: Gardie, Betty, et al.
Publicado: (2014)

Myomatous erythrocytosis syndrome: A case series
por: de Guzman, Glaiza S., et al.
Publicado: (2019)

Low incidence of EPOR mutations in idiopathic erythrocytosis
por: Filser, Mathilde, et al.
Publicado: (2020)

Immunoglobulin A Nephropathy with Erythrocytosis: An Unusual Association
por: Navaradnam, Piratheepan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9d7kkm8e81d19c6m7930n29eok